Genesystem Co., Ltd. (KOSDAQ:363250)
 6,110.00
 -210.00 (-3.32%)
  At close: Oct 28, 2025
Genesystem Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
 Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | 
|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | 
| Cash & Equivalents | 3,357 | 5,623 | 9,090 | 16,837 | 
| Short-Term Investments | 77.07 | 2,071 | 5,258 | 8,000 | 
| Trading Asset Securities | 590.67 | - | - | 1,652 | 
| Cash & Short-Term Investments | 4,024 | 7,694 | 14,348 | 26,489 | 
| Cash Growth | -66.85% | -46.37% | -45.84% | - | 
| Accounts Receivable | 1.47 | 1.78 | 74.38 | 395.53 | 
| Other Receivables | 106.71 | 109.14 | 135.91 | 162.96 | 
| Receivables | 108.18 | 110.92 | 210.29 | 558.5 | 
| Inventory | 2,033 | 1,945 | 3,094 | 3,194 | 
| Prepaid Expenses | 73.5 | 91.98 | 88.72 | 109.56 | 
| Other Current Assets | 35.8 | 138.96 | 3,299 | 111.34 | 
| Total Current Assets | 6,275 | 9,982 | 21,039 | 30,462 | 
| Property, Plant & Equipment | 8,621 | 8,652 | 6,499 | 6,012 | 
| Long-Term Investments | 3,838 | 4,278 | 3,612 | 3,895 | 
| Goodwill | 283.12 | 283.12 | 283.12 | - | 
| Other Intangible Assets | 6,242 | 6,593 | 7,320 | 684.14 | 
| Other Long-Term Assets | 130.23 | 114.74 | 174.37 | 128.83 | 
| Total Assets | 25,389 | 29,902 | 38,928 | 41,183 | 
| Accounts Payable | 8.49 | 3.13 | 8.26 | - | 
| Accrued Expenses | 153.39 | 142.69 | 316.6 | 194.6 | 
| Short-Term Debt | 940 | 850 | 850 | 850 | 
| Current Portion of Long-Term Debt | 816.62 | 923.24 | 423.24 | 90 | 
| Current Portion of Leases | 47.56 | 78.44 | 107.26 | 68.16 | 
| Current Unearned Revenue | 12.09 | - | - | 35.02 | 
| Other Current Liabilities | 406.29 | 540.31 | 726.24 | 728.2 | 
| Total Current Liabilities | 2,384 | 2,538 | 2,432 | 1,966 | 
| Long-Term Debt | 2,006 | 2,256 | 3,039 | 3,000 | 
| Long-Term Leases | 75.09 | 13.53 | 68.4 | 86.89 | 
| Pension & Post-Retirement Benefits | 1,382 | 1,249 | 1,083 | 854.89 | 
| Long-Term Deferred Tax Liabilities | 1,664 | 1,739 | 1,391 | - | 
| Other Long-Term Liabilities | 222.71 | 226.35 | 231.47 | 164.91 | 
| Total Liabilities | 7,734 | 8,021 | 8,244 | 6,073 | 
| Common Stock | 3,521 | 3,516 | 3,492 | 3,465 | 
| Additional Paid-In Capital | 12,090 | 12,031 | 11,746 | 52,383 | 
| Retained Earnings | -830.05 | 3,169 | 12,085 | -20,963 | 
| Treasury Stock | -1,518 | -1,518 | - | - | 
| Comprehensive Income & Other | 2,107 | 2,074 | 133.13 | 225.89 | 
| Total Common Equity | 15,371 | 19,273 | 27,456 | 35,110 | 
| Minority Interest | 2,285 | 2,609 | 3,227 | - | 
| Shareholders' Equity | 17,656 | 21,881 | 30,684 | 35,110 | 
| Total Liabilities & Equity | 25,389 | 29,902 | 38,928 | 41,183 | 
| Total Debt | 3,885 | 4,121 | 4,488 | 4,095 | 
| Net Cash (Debt) | 139.45 | 3,574 | 9,860 | 22,394 | 
| Net Cash Growth | -98.19% | -63.75% | -55.97% | - | 
| Net Cash Per Share | 20.51 | 522.08 | 1418.86 | 3244.73 | 
| Filing Date Shares Outstanding | 6.82 | 7.03 | 6.98 | 6.93 | 
| Total Common Shares Outstanding | 6.82 | 7.03 | 6.98 | 6.93 | 
| Working Capital | 3,890 | 7,444 | 18,608 | 28,496 | 
| Book Value Per Share | 2253.61 | 2740.40 | 3930.80 | 5066.46 | 
| Tangible Book Value | 8,846 | 12,397 | 19,853 | 34,426 | 
| Tangible Book Value Per Share | 1296.94 | 1762.68 | 2842.23 | 4967.73 | 
| Land | 5,915 | 5,915 | 3,538 | 3,538 | 
| Buildings | 1,637 | 1,637 | 1,637 | 1,637 | 
| Machinery | 2,241 | 2,167 | 1,934 | 1,150 | 
| Construction In Progress | 61.95 | - | 37.75 | 21.42 | 
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.